| 臺大學術典藏 |
2019-11-27T06:54:17Z |
Long-term outcomes of surgical treatment for intravascular leiomyomatosis
|
Yu H.-Y.;Tsai H.-E.;Chi N.-H.;Kuo K.-T.;Wang S.-S.;Chen C.-A.;Yih-Sharng Chen; Yu H.-Y.; Tsai H.-E.; Chi N.-H.; Kuo K.-T.; Wang S.-S.; Chen C.-A.; YIH-SHARNG CHEN |
| 臺大學術典藏 |
2020-03-07T06:42:04Z |
Long-term outcomes of surgical treatment for intravascular leiomyomatosis
|
KUAN-TING KUO; Wang S.-S.; Chen C.-A.; Chen Y.-S.; Yu H.-Y.;Tsai H.-E.;Chi N.-H.;Kuan-Ting Kuo;Wang S.-S.;Chen C.-A.;Chen Y.-S.; Yu H.-Y.; Tsai H.-E.; Chi N.-H. |
| 臺大學術典藏 |
2021-05-06T02:57:45Z |
Long-term outcomes of surgical treatment for intravascular leiomyomatosis
|
Yu H.-Y.; Tsai H.-E.; NAI-HSIN CHI; Kuo K.-T.; Wang S.-S.; Chen C.-A.; Chen Y.-S. |
| 國家衛生研究院 |
2022-11 |
Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes
|
Yen, FS;Wei, JCC;Hung, YT;Hsu, CC;Hwu, CM |
| 國立成功大學 |
2018-08-31 |
Long-term outcomes of total ureterectomy with ileal-ureteral substitution treatment for ureteral cancer: a single-center experience
|
Ou;Yin-Chien;Hu;Che-Yuan;Cheng;Hong-Lin;Yang;Wen-Horng |
| 臺大學術典藏 |
2018-09-10T18:05:40Z |
Long-term outcomes of totally implantable venous access devices
|
CHIH-PENG LIN; CHI-HSIANG HUANG; Wang, Y.-C. And Lin, P.-L. And Chou, W.-H. And Lin, C.-P. And Huang, C.-H. |
| 中山醫學大學 |
2020 |
Long-term outcomes of trans-oral robotic surgery-assisted total laryngectomy for recurrent laryngeal cancers
|
Wang, CC; Lin, WJ; De Virgilio, A; Liu, SA; Chen, SH; Liao, JS |
| 中山醫學大學 |
2021 |
Long-term outcomes of trans-oral robotic surgery-assisted total laryngectomy for recurrent laryngeal cancers (vol 50, pg 653, 2020)
|
Wang, CC; Lin, WJ; De Virgilio, A; Liu, SA; Chen, SH; Liao, JS |
| 國立臺灣大學 |
1999 |
Long-Term Outcomes Studies of Hyperactive Children: Literature Review
|
蔡景宏; 高淑芬; TSAI, CHING-HUNG; GAU, SUSAN SHUR-FEN |
| 臺大學術典藏 |
2021-04-23T05:56:26Z |
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
|
Awad M.M.;Gadgeel S.M.;Borghaei H.;Patnaik A.;Chih-Hsin Yang;Powell S.F.;Gentzler R.D.;Martins R.G.;Stevenson J.P.;Altan M.;Jalal S.I.;Panwalkar A.;Gubens M.;Sequist L.V.;Saraf S.;Zhao B.;Piperdi B.;Langer C.J.; Awad M.M.; Gadgeel S.M.; Borghaei H.; Patnaik A.; CHIH-HSIN YANG; Powell S.F.; Gentzler R.D.; Martins R.G.; Stevenson J.P.; Altan M.; Jalal S.I.; Panwalkar A.; Gubens M.; Sequist L.V.; Saraf S.; Zhao B.; Piperdi B.; Langer C.J. |
